tiprankstipranks
Trending News
More News >
China Shineway Pharmaceutical Group Limited (HK:2877)
:2877
Hong Kong Market

China Shineway Pharmaceutical Group Limited (2877) Ratios

Compare
0 Followers

China Shineway Pharmaceutical Group Limited Ratios

HK:2877's free cash flow for Q4 2024 was ¥0.74. For the 2024 fiscal year, HK:2877's free cash flow was decreased by ¥ and operating cash flow was ¥0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.51 3.35 4.07 5.19 4.62
Quick Ratio
3.18 2.98 3.68 4.65 4.25
Cash Ratio
2.51 2.42 3.02 3.83 3.30
Solvency Ratio
0.39 0.45 0.49 0.57 0.35
Operating Cash Flow Ratio
0.39 0.38 0.67 0.64 0.53
Short-Term Operating Cash Flow Coverage
2.92 3.11 0.00 0.00 1.73
Net Current Asset Value
¥ 6.02B¥ 5.62B¥ 4.93B¥ 4.40B¥ 4.10B
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.03 <0.01 <0.01 0.05
Debt-to-Equity Ratio
0.05 0.04 <0.01 <0.01 0.07
Debt-to-Capital Ratio
0.04 0.04 <0.01 <0.01 0.06
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.34 1.36 1.29 1.22 1.24
Debt Service Coverage Ratio
2.07 3.80 1.44K 590.36 1.35
Interest Coverage Ratio
137.48 356.42 1.13K 426.13 25.45
Debt to Market Cap
0.05 0.06 0.00 0.00 0.11
Interest Debt Per Share
0.47 0.40 0.01 0.02 0.54
Net Debt to EBITDA
-5.78 -3.93 -4.55 -4.64 -5.73
Profitability Margins
Gross Profit Margin
74.95%75.15%74.38%74.77%74.85%
EBIT Margin
22.13%27.52%23.23%22.38%15.50%
EBITDA Margin
26.52%31.44%27.93%28.04%23.35%
Operating Profit Margin
22.30%21.60%18.06%16.58%15.91%
Pretax Profit Margin
30.33%27.46%23.21%22.34%14.87%
Net Profit Margin
22.24%21.47%18.30%17.27%11.11%
Continuous Operations Profit Margin
22.24%21.47%18.30%17.27%11.11%
Net Income Per EBT
73.32%78.17%78.82%77.30%74.69%
EBT Per EBIT
135.97%127.14%128.51%134.76%93.52%
Return on Assets (ROA)
8.37%10.13%8.78%7.73%4.09%
Return on Equity (ROE)
11.25%13.78%11.32%9.43%5.09%
Return on Capital Employed (ROCE)
11.10%13.66%10.87%8.75%7.02%
Return on Invested Capital (ROIC)
7.79%10.25%8.58%6.78%5.06%
Return on Tangible Assets
8.53%10.34%9.01%7.98%4.17%
Earnings Yield
12.25%19.12%14.28%13.14%8.73%
Efficiency Ratios
Receivables Turnover
3.14 3.58 4.05 -745.67 -499.66
Payables Turnover
2.35 2.32 3.28 3.56 4.06
Inventory Turnover
1.16 1.25 1.54 1.38 1.51
Fixed Asset Turnover
3.10 3.75 3.25 2.57 1.90
Asset Turnover
0.38 0.47 0.48 0.45 0.37
Working Capital Turnover Ratio
0.64 0.83 0.81 0.72 0.64
Cash Conversion Cycle
274.34 236.13 215.89 160.79 151.54
Days of Sales Outstanding
116.11 101.86 90.09 -0.49 -0.73
Days of Inventory Outstanding
313.66 291.93 237.12 263.90 242.11
Days of Payables Outstanding
155.43 157.65 111.32 102.61 89.84
Operating Cycle
429.77 393.78 327.21 263.41 241.38
Cash Flow Ratios
Operating Cash Flow Per Share
1.27 1.23 1.47 0.93 0.84
Free Cash Flow Per Share
1.09 1.04 1.30 0.81 0.76
CapEx Per Share
0.19 0.19 0.17 0.12 0.09
Free Cash Flow to Operating Cash Flow
0.85 0.85 0.88 0.87 0.90
Dividend Paid and CapEx Coverage Ratio
1.76 2.02 2.99 1.29 2.08
Capital Expenditure Coverage Ratio
6.87 6.46 8.57 7.51 9.67
Operating Cash Flow Coverage Ratio
2.78 3.10 149.11 47.16 1.63
Operating Cash Flow to Sales Ratio
0.25 0.21 0.28 0.22 0.24
Free Cash Flow Yield
12.00%15.54%19.36%14.38%16.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
8.17 5.23 7.00 7.61 11.45
Price-to-Sales (P/S) Ratio
1.82 1.12 1.28 1.31 1.27
Price-to-Book (P/B) Ratio
0.92 0.72 0.79 0.72 0.58
Price-to-Free Cash Flow (P/FCF) Ratio
8.33 6.43 5.16 6.95 5.90
Price-to-Operating Cash Flow Ratio
7.12 5.44 4.56 6.03 5.29
Price-to-Earnings Growth (PEG) Ratio
-0.61 0.16 0.24 0.08 -0.29
Price-to-Fair Value
0.92 0.72 0.79 0.72 0.58
Enterprise Value Multiple
1.06 -0.36 0.04 0.05 -0.28
Enterprise Value
EV to EBITDA
1.06 -0.36 0.04 0.05 -0.28
EV to Sales
0.28 -0.11 0.01 0.01 -0.06
EV to Free Cash Flow
1.29 -0.65 0.04 0.08 -0.30
EV to Operating Cash Flow
1.11 -0.55 0.04 0.07 -0.27
Tangible Book Value Per Share
9.62 9.03 8.17 7.51 7.47
Shareholders’ Equity Per Share
9.87 9.29 8.45 7.82 7.66
Tax and Other Ratios
Effective Tax Rate
0.27 0.22 0.21 0.23 0.25
Revenue Per Share
4.99 5.96 5.23 4.27 3.51
Net Income Per Share
1.11 1.28 0.96 0.74 0.39
Tax Burden
0.73 0.78 0.79 0.77 0.75
Interest Burden
1.37 1.00 1.00 1.00 0.96
Research & Development to Revenue
0.03 0.02 0.03 0.03 0.04
SG&A to Revenue
0.08 0.07 0.07 0.08 0.10
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 <0.01
Income Quality
0.84 0.75 1.54 1.26 2.16
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis